Developing Pharmacy Practice - FIP

Developing Pharmacy Practice A focus on patient careHANDBOOK 2006 EDITIONK arin WiedenmayerSwiss Tropical Institute, Basel, SwitzerlandRob S. SummersSchool of Pharmacy , University of Limpopo, MEDUNSA Campus, South AfricaClare A. MackieMedway School of Pharmacy , The Universities of Greenwich and Kent, Chatham Maritime, United KingdomAndries G. S. GousSchool of Pharmacy , University of Limpopo, MEDUNSA Campus, South AfricaMarthe EverardDepartment of Medicines Policy and Standards, World Health Organization, Geneva, SwitzerlandWith contributions from Dick Tromp (Chairman of the Board of Pharmaceutical Practice of the International Pharmaceutical Federation, The Hague, The Netherlands)World Health OrganizationDepartment of Medicines Policy and StandardsGeneva, SwitzerlandIn collaboration withInternational Pharmaceutical Federation The Hague, The NetherlandsWHO/PSM/ World Health Organization and International Pharmaceutical Federation 2006 All rights designation employed and the presentation of the material in this report including tables and maps, do not imply the expression of any opinion whatsoever on the part of the World Health Organization and the International Pharmaceutical Federation concerning the legal status of any country, territory, city or area or of authorities or concerning the delimitation of its frontiers or boundaries.

Appendix 2: Example of pharmacoeconomic analysis: Thrombolytics for acute myocardial infarction (a hypothetical exercise) 83 Appendix 3: Answers to self-assessment questions, exercises and learning activities 85 iv DEVELOPING PHARMACY PRACTICE – A FOCUS ON PATIENT CARE.

Loading..

Tags:

  Myocardial, Infractions, Thrombolytic, Myocardial infarction

Information